Bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) is a recently approved single-tablet antiretroviral regimen and is recommended as a first-line agent. No cases of gynecomastia were reported in clinical trials. We report development of ultrasound-confirmed gynecomastia in a previously antiretroviral-naïve patient approximately two months after starting BIC/FTC/TAF, which resolved ten weeks after discontinuing bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) based therapy.
KarrasALafaurieMFurcoA, et al.
Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis2003;
36: 1070–1073.
4.
NjugunaCSwartABlockmanM, et al.
Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa. AIDS Res Ther2016;
13: 40.
5.
MiraJALozanoFSantosJ, et al.
Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment. Antivir Ther2004;
9: 511–517.
NaranjoCABustoUSellersEM, et al.
A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;
30: 239–245.
9.
JoverFCuadradoJMRoigP, et al.
Efavirenz-associated gynecomastia: report of five cases and review of the literature. Breast J2004;
10: 244–246.
10.
SikoraMJRaeJMJohnsonMD, et al.
Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth. HIV Med2010;
11: 603–607.
11.
QaziNAMorleseJFKingDM, et al.
True gynaecomastia, another manifestation of immune reconstitution disease?Int J STD AIDS2002;
13: 59–65.
12.
KatanoMMatsuoTMorisakiT, et al.
Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2. Cancer Immunol Immunother1994;
39: 161–166.
13.
SinghAPurohitAGhilchikMW, et al.
The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2. Endocr Relat Cancer1999;
6: 139–147.
14.
PsichogiouMBasoulisDTsikala-VafeaM, et al.
Integrase strand transfer inhibitors and the emergence of Immune Reconstitution Inflammatory Syndrome (IRIS). Curr HIV Res2017;
15: 405–410.
15.
NovakRMRichardsonJTBuchaczK, et al.
Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS2012;
26: 721–730.
